ALPINE IMMUNE SCIENCES, INC. Deferred Tax Assets, Gross
ALPINE IMMUNE SCIENCES, INC. had Deferred Tax Assets, Gross of $65.86 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2024-03-20
- 2023-12-31: Deferred Tax Assets, Gross $65.86M.
- 2022-12-31: Deferred Tax Assets, Gross $57.08M.
- 2021-12-31: Deferred Tax Assets, Gross $41.06M.
- 2020-12-31: Deferred Tax Assets, Gross $30.09M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2023-12-31 | $65.86M 10-K · filed 2024-03-20 |
| 2022-12-31 | $57.08M 10-K · filed 2024-03-20 |
| 2021-12-31 | $41.06M 10-K · filed 2023-03-23 |
| 2020-12-31 | $30.09M 10-K · filed 2022-03-17 |
| 2019-12-31 | $24.40M 10-K · filed 2021-03-18 |
| 2018-12-31 | $13.96M 10-K · filed 2020-03-30 |
| 2017-12-31 | $3.84M 10-K · filed 2019-03-18 |
| 2016-12-31 | $1.00M 10-K · filed 2018-03-28 |